secwatch.observer — SEC 8-K summary
======================================

Issuer:     CITIUS ONCOLOGY, INC. (CTOR)
CIK:        0001851484
Form:       8-K
Filed at:   2025-08-18T23:59:59+00:00
Accession:  0001213900-25-078018
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Oncology files prospectus supplement to update S-1 registration statement following 10-Q filing
--------------------------------------------------------------------------------

- Prospectus supplement filed August 18, 2025; original S-1 effective July 15, 2025.
- Public offering of common stock and warrants closed July 17, 2025.
- Supplement needed because Citius Oncology not yet eligible to incorporate 10-Q by reference into S-1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851484/000121390025078018/0001213900-25-078018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851484/000121390025078018/ea0253763-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-078018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer